To examine the possible therapeutic potential of decoy oligonucleotides against splicing factors, we designed a decoy oligonucleotide against another splicing factor, PTBP1, which is upregulated in several cancers and promotes pro-oncogenic splicing events23,33–35. Here, SLU7 is linked to cancer.